pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,342 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 47 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: device recall×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,342
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05859191: Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

    Sponsor: University Hospital, Tours. Phase: . Conditions: Systemic Lupus Erythematosus, Physiopathology

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06583174: Evaluation of the Relationship Between Breastfeeding Attitudes and Nutrition Knowledge Levels

    Sponsor: Nigde Omer Halisdemir University. Phase: . Conditions: Breastfeeding

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06089174: Assessment of the Increased Risk of Infection Following an Ultratrail

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: NA. Conditions: Running, Immune Deficiency, Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07082218: Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury, Treatment, Sleep Health, Depression, Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07701590: CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

    Sponsor: Capsicure, LLC. Phase: NA. Conditions: Wound, Foot, Diabetic Foot Ulcer (DFU), Venus Leg Ulcer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07618897: Efficacy of Sub-laminar and/or Interspinous Tethers to Prevent Proximal Junctional Kyphosis After Surgical Correction of Adult Spinal Deformity

    Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Proximal Junctional Kyphosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06352710: Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment

    Sponsor: Cantonal Hospital of St. Gallen. Phase: . Conditions: Disc Disease, Instabilities Lumbar, Brain Tumor, Aneurysm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06318910: Customized Foot Orthoses on Muscle Activity During Standing and Gait in Plantar Heel Pain

    Sponsor: Mahidol University. Phase: NA. Conditions: Foot Orthoses, Fasciitis, Plantar

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04723810: TumorGlow Intraoperative Molecular Imaging (IMI)

    Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Tumor, Solid

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07071610: A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis

    Sponsor: Lynk Pharmaceuticals Co., Ltd. Phase: PHASE2. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06022510: Safety and Efficacy of Fetoscopes Used in Fetoscopic Selective Laser Photocoagulation

    Sponsor: Michael A Belfort. Phase: NA. Conditions: Twin Monochorionic Diamniotic Placenta

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07534982: Success Rates of Expectant vs. Medical Management for Retained Products After First-Trimester Abortion: Randomized Controlled Trial

    Sponsor: Yael Yagur. Phase: NA. Conditions: Retained Product of Conception After First Trimester Medical Abortion

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07423520: HemodynamIc eFfects of Lung Collapse and overdIstension During ARDS

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: ARDS, AHRF

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07520123: Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: NA. Conditions: Chronic Hepatitis B

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07733323: Respiratory Physiotherapy for Patients With Bronchiectasis

    Sponsor: Yolanda Sanesteban Hermida. Phase: . Conditions: Bronchiectasis Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06560359: RCT on the Neurobehavioral Effects of Fruits and Vegetables in Shanghai Children

    Sponsor: Fudan University. Phase: NA. Conditions: Cognitive Function, Mood Disorders, Attention-deficit

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06878859: Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Depression - Major Depressive Disorder, Cannabis Use Disorder, Mental Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06403280: The Effect of Alcohol on Common Tremor Syndromes

    Sponsor: Medical University of Graz. Phase: NA. Conditions: Essential Tremor, Dystonia, Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03898180: Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Urothelial Carcinoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06315296: An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

    Sponsor: Thomas Jefferson University. Phase: NA. Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Carcinoma, Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07725796: A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

    Sponsor: UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.. Phase: PHASE1. Conditions: Bladder (Urothelial, Transitional Cell) Cancer, NMIBC, Urothelial Carcinoma Bladder, Urothelial Carcinoma in Situ, Urothelial Carcinoma Recurrent, Urothelial Carcinoma of the Urinary Bladder, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer (NMIBC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06679062: Suvorexant for Treatment of AUD and PTSD

    Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance. Phase: PHASE2. Conditions: Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04989946: Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

    Sponsor: University of Wisconsin, Madison. Phase: PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633288: A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

    Sponsor: SynAct Pharma Aps. Phase: PHASE2. Conditions: Respiratory Viral Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07585903: The Effect of Family-Centered Care Practices In Pediatric Intensive Care Unit

    Sponsor: Zonguldak Bulent Ecevit University. Phase: NA. Conditions: Pediatric Intensive Care

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06924827: A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

    Sponsor: Elizabeth Donner. Phase: PHASE4. Conditions: Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07003061: Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery

    Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Gastrointestinal Cancer, Sarcopenia, Neuromuscular Blockade

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05908461: The Early Childhood Friendship Project - Phase 3

    Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07674927: Pilot Study Exploring the Effects of Rhythmic Auditory Stimulation on Gait in People With Motor Incomplete Spinal Cord Injury

    Sponsor: University of California, Davis. Phase: NA. Conditions: Spinal Cord Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06826742: Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

    Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Cesarean Delivery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01469442: Postoperative Biliary Fistula Prevention After Hepatectomy

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Hepatectomy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07533942: A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

    Sponsor: Jazz Pharmaceuticals. Phase: PHASE2. Conditions: Meningioma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07667686: French Validation of the Recovery Assessment Scale (RAS-FR)

    Sponsor: Etablissement Public de Santé Mentale de Metz-Jury. Phase: . Conditions: Mental Health, Psychiatric Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07026786: Using Mindfulness in an Enhanced Recovery After Surgery Protocol to Support Recovery After Colorectal Surgery

    Sponsor: University Hospitals Cleveland Medical Center. Phase: NA. Conditions: Pain After Surgery, Anxiety After Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07224061: Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools

    Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Asthma in Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03598361: Mineral Status in Pregnant Women

    Sponsor: Poznan University of Life Sciences. Phase: . Conditions: Pregnancy; Disorder, Blood

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05625061: Just-in-time Adaptive Intervention Messaging in a Digital Weight Loss Intervention for Young Adults

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Obesity, Overweight, Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07667673: Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH

    Sponsor: Istanbul University - Cerrahpasa. Phase: . Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Right Ventricular Function

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07551869: Oxygen as a Metabolic Modulator: Divergent Physiological Adaptations to Hypoxic and Hyperoxic Tabata Training.

    Sponsor: Haute Ecole Bruxelles-Brabant. Phase: NA. Conditions: Hyperoxia / High FiO₂ Exposure, Interval Training, HIIT, High Intensity Interval Training, VO2max, Hypoxia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07668583: EFFICACY AND SAFETY OF ZOLEDRONATE VERSUS PLACEBO ON PAIN AT WEEK 12 IN PEDIATRIC PATIENTS WITH CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Osteomyelitis Chronic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07676383: Precision Navigation to Improve Community Cancer Screening Participation

    Sponsor: Hunan Cancer Hospital. Phase: NA. Conditions: Cancer Screening, Lung Cancer, Breast Cancer, Colorectal Cancer, Upper Gastrointestinal Cancer, Liver Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07673783: Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451483: Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

    Sponsor: Jules Bordet Institute. Phase: . Conditions: Ventral Hernias, Cytoreductive Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05934708: Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

    Sponsor: University of Southern California. Phase: NA. Conditions: Inflammatory Response

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03684876: Association Between Renal and Right Cardiac Functions After Urinary Sodium Depletion Following Cardiac Surgery

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Cardiorenal Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07579117: Endoscopic Video-Assisted Nipple-Sparing Mastectomy

    Sponsor: European Institute of Oncology. Phase: NA. Conditions: Endoscopic Video-assisted Nipple-sparing Mastectomy, Breast Surgery, Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07603817: Association Between Overt and Sub-clinical Primary Hypothyroidism and Metabolic Dysfunction-Associated Steatoic Liver Disease in Non-Diabetic Patients

    Sponsor: Sohag University. Phase: . Conditions: Overt, Sub-clinical, Primary Hypothyroidism, Metabolic Dysfunction-Associated Steatoic Liver Disease, Non-Diabetic Patients

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334340: Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease

    Sponsor: Vastra Gotaland Region. Phase: NA. Conditions: Pediatric Crohns Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06931340: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE3. Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07667868: A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BP2202 in Patients With Relapsed/Refractory Multiple Myeloma

    Sponsor: BrightPath Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (RRMM)

    full page →ctgov ↗
    ← prev
    page 103 of 104
    next →